1.Umbilical cord blood mesenchymal stem cell transplantation in 20 patients with multiple system atrophy
Like WU ; Xiaojuan WANG ; Baolei XU ; Shuangshuang LIU ; Saichun CHU ; Bo CHENG
Chinese Journal of Tissue Engineering Research 2009;13(45):8975-8978
OBJECTIVE:To observe the outcomes of umbilical cord blood mesenchymal stem call transplantation for treating neural function of multiple system atrophy (MSA) patients.METHODS:A total of 20 MSA patients were selected at the Beijing Wu Stem Cells Medical Center from January to October 2008.All patients received treatment of vessel distention,anti-free radical,trophic nerve and call membrane stabilization,as well as umbilical cord blood mesenchymal stem call transplantation via intrathecal injection.Patients at left-lateral position,and body bent at hips,knees and necks.Acupuncture was conducted at the space of lumbar vertebra 3 and 4.Following local anesthesia,No.9 needle was directly pricked into the subarachnoid cavity.2 mg dexamethasone was slowly infused,and 5 mL (5×106 stem cells) umbilical cord blood mesenchymal stern call injection was obtained and slowly infused into the subarachnoid cavity within 10 minutes,once per week,four times as a course,totally one course.We adopted Unified Multiple System Atrophy Rating Scale (UMSARS) to evaluate those MSA patients.The higher score represented a severe pathogenetic condition.RESULTS:Compared with pretransplantation,the UMSARS score was significantly decreased in 20 patients 4 weeks follwing transplantation (P < 0.01).After the treatment,patient's clinical symptoms such as slow movement,balance disturbance,orthostatic hypotension,urinary and bowel disorders had full obvious improvement.Graft versus host disease was not found.CONCLUSION:It is indicated that mesenchymal stem call transplantation is effective,can partly improve MSA patients' clinical symptoms,and improve patients' life quality.
2.LEFT VENTRICULAR MASS IN ATHLETES WITH AND WITHOUT ELECTROCAR DIOGRAPHIC LEFT VENTRICULAR HYPERTROPHY
Fumei LIN ; Chongxuan GAO ; Jiexin BAI ; Gaoqu HUANG ; Saichun WANG ; Zhishen ZHANG ;
Chinese Journal of Sports Medicine 1982;0(02):-
In order to determine the pathophysiologic significance of electrocardiographic ventricular hypertrophy in athletes (LVH ath), echocardiographic measurements of left ventricular mass (LVM) were performed on 50 LVH ath. and 50 non-LVH matched ath. They were members of National Teams of track and field, swimming, football and cycling, with an average age of 20.74?3.3 years. Anatomic validation of the method was used for calculation of LVM in this study. Comparisons of LVM were made between LVH ath. and non-LVH ath., and between non-LVH ath. and the untrained:LVM=1.04?[(LVID+PWT+IVST)~3-(LVID)~3]-14Results showed no significant difference of LVM between LVH ath. and non-LVH ath. while LVM of non-LVH ath. were considerably greater than that of the untrained (P
3.A case report of polyglandular syndrome induced by programmed death-1 inhibitor and literature review
Yao WANG ; Bao LI ; Saichun ZHANG ; Weijun GU ; Yu CHENG ; Qi NI ; Chaohui LYU ; Jianming BA ; Jintao DOU ; Yiming MU
Chinese Journal of Endocrinology and Metabolism 2021;37(5):462-466
We reported a case of polyglandular syndrome induced by programmed death-1(PD-1) inhibitors. The patient was a 51-years-old male with non-small cell lung cancer, treated with PD-1 inhibitor nivolumab/pembrolizumab because of postoperative subcarinal lymph node metastasis indicated by PET-CT. During 14 cycles of PD-1 inhibitor treatment, the patient successively developed primary hypothyroidism, and type 1 diabetes mellitus(T1DM). More than five months after the withdrawal of pembrolizumab, the patient experienced recurrentce. Laboratory examinations showed mild hyponatremia and hypopituitarism including ACTH and growth hormone(GH)/insulin-like growth factor-1(IGF-1) insufficiency. This is the first report of a patient diagnosed as polyglandular syndrome caused by PD-1 inhibitor. In particularly, the hypothyroidism and T1DM did not improve after drug withdrawal, while hypopituitarism was further aggravated. This case reminds us that we should pay more attention to the changes of endocrine function during and after the treatment of PD-1 inhibitor, so that we can make the correct diagnosis and take proper medical measures timely, to avoide missed diagnosis, and improper treatment.
4.The effect of comprehensive nursing intervention in children cases with severe hand-foot-mouth disease complicated with encephalitis
Jiabei WU ; Huaping WANG ; Saichun ZHANG ; Shiyong ZHAO
China Modern Doctor 2014;(29):69-72
Objective To investigate the application effect of comprehensive nursing care for severe hand-foot-mouth disease (HFMD) complicated with encephalitis. Methods A total of 70 children cases with severe HFMD complicated with encephalitis induced by enterovirus 71 infection admitted in our hospital from May 2012 to August 2013 were di-vided into observation group 35 cases and control group 35 cases. The control group was given symptomatic care, the observation group was given comprehensive nursing intervention. The fever and herpes subsided time, fatigue and limb shaking disappearance time, the average length of stay in hospital and the rate of complications were compared between two groups. Results The fever and herpes subsided time, fatigue and limb shaking disappearance time, the average hos-pitalization time in the observation group were shorter than the control group statistically (P<0.05 or P<0.01), hospital-ization time of the observation group was significantly shorter than the control group(P<0.01). The occurrence of compli-cations in the observation group were reduced in the observation group compared to the control group (P<0.01). Conclu-sion Comprehensive nursing intervention in children cases with severe type of HFMD complicated with encephalitis, combined with regular treatment, can reduce the incidence of complications and promote disease recovery.